News
BMS bags first approval for myeloma CELMoD Zenbexus
Bristol Myers Squibb's CELMoD pipeline has delivered its first approval, for iberdomide, as part of a combination regimen for multiple myeloma.
News
MFN affecting Swiss medicines access, says Interpharma
Pharma groups have held back from submitting around a third of their new medicines for reimbursement in Switzerland, impeding patient access.
News
ICER says AZ's new hypertension drug too expensive
ICER says that AstraZeneca's first-in-class Baxfendy and a rival drug from Mineralys are not cost-effective as therapies for resistant hypertension.
News
Another 340B lawsuit gets underway, in Illinois
Three pharma groups have opened a new front in their legal challenge to the federal 340B drug pricing programme in the US.
News
Manufacturing issues mar ITM's radiopharma filing, says FDA
ITM's first attempt to score FDA approval for one of its radiopharma therapies has been knocked back by the agency.
News
Press Releases
Views & Analysis
Editor's Picks
Editor's Picks
